Search results
Results From The WOW.Com Content Network
Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells.
In February 2002, there was a further merger with COR Therapeutics [4] [5] —among the largest such mergers in the history of the biotech industry at that time. In addition to creating a strong pipeline of novel therapeutics, the merger added cardiovascular research and drug development to the company's other key therapeutic areas: oncology ...
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment . The company was founded in 1998 and went public in 2004.
Melinta Therapeutics, founded in 2000 as Rib-X Pharmaceuticals, is an American publicly traded biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital settings.
Galena Biopharma, Inc. (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company based in San Ramon, California.The company was founded in Worcester, Massachusetts.
Belharra, (Basque: Belarra, literally "grass, weed") is a reef and a surf spot in France located off Saint-Jean-de-Luz in the Northern Basque Country, in the department of Pyrénées-Atlantiques, France. The shoal creates a violent wave.
The filing pathway requires more testing than for small-molecule generics, but less testing than for registering completely new therapeutics. [ 20 ] In 2003, the European Medicines Agency introduced an adapted pathway for biosimilars, termed similar biological medicinal products .
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Professor Allan Bradley, FRS and Professor Bradley's postdoctoral fellow Arthur T Sands. [2]